Principal Scientist, Vancive Medical Technologies, Turnhout, N/A, BelgiumAnne Wibaux has more than 15 years of experience developing wound care dressings. She has 4 granted patents and 10 pending applications in the field of antimicrobial and adhesive. Anne was the first to have resolved the challenge of incorporating Chlorhexidine gluconate into an adhesive.
F100 – Oral Abstract Presentations (F100)
2:45 PM - 3:00 PM
Room: Chesapeake 4-6
CE Hours: 1.2 per four (4) 15-minute sessions
Principal Scientist, Vancive Medical Technologies, Turnhout, N/A, Belgium
Purpose: To cover IV sites chlorhexidine gluconate-impregnated dressings in the form of a sponge or a gel are employed, both of which can be cumbersome to use and cost prohibitive for wide spread adoption. An alternative chlorhexidine gluconate impregnated adhesive is now available in the form of a simple semi-breathable polyurethane film. The antimicrobial efficacy and fluid management were tested in comparison to transparent semi-permeable polyurethane adhesive film dressings which are popular means of covering catheter sites. Methods: The adhesive film containing chlorhexidine gluconate was tested using the EN13726 and the Jis Z2801:2010 standard. Results: The adhesive film containing chlorhexidine gluconate has demonstrated: - Greater than 4.0 Log10 Reduction on bacteria and yeast from day 1 through day 7. - Fluid Handling Capacity equivalent to that of an advanced wound care hydrocolloid. Limitations: The study was conducted In Vitro. Conclusion: The adhesive film containing chlorhexidine gluconate, has similar properties to a film dressing (easy to use, breathable, transparent) on top of featuring fluid absorption properties similar to that of hydrocolloid dressings.